| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kah Hui Yap, Nurul Husna Baharudin, Abdul Halim Abdul Gafor, Rabani Remli, Shen-Yang Lim, Wan Asyraf Wan Zaidi, Shahrul Azmin, Shahizon Azura Mohamed Mukari, Raihanah Abdul Khalid, Norlinah Mohamed Ibrahi. Movement Disorders Resulting From Bilateral Basal Ganglia Lesions in End-Stage Kidney Disease: A Systematic Review. Journal of movement disorders. 2022-05-25. PMID:35614016. |
the basal ganglia (bg) are susceptible to fluctuations in blood urea levels, sometimes resulting in movement disorders. |
2022-05-25 |
2023-08-13 |
Not clear |
| Zeshan Shabbir Sipra, Islah Ud Din, Muhammad Arqam Awais, Taimoor Ali Tari. Fahr's disease: A rare neuropsychiatric disorder. JPMA. The Journal of the Pakistan Medical Association. vol 72. issue 2. 2022-03-23. PMID:35320202. |
fahr's disease is a rare clinical neurodegenerative entity, occurring mainly in 4th or 5th decade, showing gradually progressive bilateral symmetric calcifications in basal ganglia, subcortical white matter, thalami or cerebellum, which can lead to movement disorder and/or neuropsychiatric manifestations. |
2022-03-23 |
2023-08-13 |
Not clear |
| Sasivimol Virameteekul, Roongroj Bhidayasir. We Move or Are We Moved? Unpicking the Origins of Voluntary Movements to Better Understand Semivoluntary Movements. Frontiers in neurology. vol 13. 2022-03-10. PMID:35265031. |
yet, they reflect an impairment of prefrontal cortices and related circuits rather than simple motor systems, which results in the absence of subjective recognition of the movements, in contrast to other neurological movement disorders where principal abnormalities are located within the basal ganglia and its connections. |
2022-03-10 |
2023-08-13 |
human |
| Praneet Kaur Marwah, Gijong Paik, Christopher J Issa, Christopher C Jemison, Muhammad B Qureshi, Tareq M Hanna, Eduardo Palomino, Krishna Rao Maddipati, David Nju. Manganese-Stimulated Redox Cycling of Dopamine Derivatives: Implications for Manganism. Neurotoxicology. 2022-02-26. PMID:35217070. |
manganism, the condition caused by chronic exposure to high levels of manganese, selectively targets the dopamine-rich basal ganglia causing a movement disorder with symptoms similar to parkinson's disease. |
2022-02-26 |
2023-08-13 |
Not clear |
| Oliver Van Oekelen, Adolfo Aleman, Bhaskar Upadhyaya, Sandra Schnakenberg, Deepu Madduri, Somali Gavane, Julie Teruya-Feldstein, John F Crary, Mary E Fowkes, Charles B Stacy, Seunghee Kim-Schulze, Adeeb Rahman, Alessandro Laganà, Joshua D Brody, Miriam Merad, Sundar Jagannath, Samir Parek. Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature medicine. 2021-12-11. PMID:34893771. |
here, we describe the case of a patient with mm who was enrolled in the cartitude-1 trial ( nct03548207 ) and who developed a progressive movement disorder with features of parkinsonism approximately 3 months after ciltacabtagene autoleucel bcma-targeted car-t cell infusion, associated with car-t cell persistence in the blood and cerebrospinal fluid, and basal ganglia lymphocytic infiltration. |
2021-12-11 |
2023-08-13 |
human |
| Konstantinos Spiliotis, Jens Starke, Denise Franz, Angelika Richter, Rüdiger Köhlin. Deep brain stimulation for movement disorder treatment: exploring frequency-dependent efficacy in a computational network model. Biological cybernetics. 2021-12-11. PMID:34894291. |
a large-scale computational model of the basal ganglia network and thalamus is proposed to describe movement disorders and treatment effects of deep brain stimulation (dbs). |
2021-12-11 |
2023-08-13 |
Not clear |
| Mihael Emilov Tsalta-Mladenov, Darina Kirilova Georgieva, Silva Peteva Andonov. Hyperglycemic hemichorea due to diabetic striatopathy: case-based review. Current medical research and opinion. 2021-12-07. PMID:34873977. |
ds predominantly leads to a unilateral reversible injury of the basal ganglia resulting in various movement disorders such as hemichorea and hemibalismus. |
2021-12-07 |
2023-08-13 |
Not clear |
| Ritwik Ghosh, Souvik Dubey, Subhankar Chatterjee, Mrinalkanti Ghosh, Biman Kanti Ray, Julián Benito-Leó. Hypermanganesemia Induced Chorea and Cognitive Decline in a Tea Seller. Tremor and other hyperkinetic movements (New York, N.Y.). vol 10. 2021-11-15. PMID:33178484. |
this neurotoxic element has predilection for depositing in basal ganglia structures, manifesting mainly as parkinsonian and dystonic movement disorders with behavioral abnormalities. |
2021-11-15 |
2023-08-13 |
Not clear |
| Sanne Moorman, Jae-Rong Ahn, Mimi H Ka. Plasticity of stereotyped birdsong driven by chronic manipulation of cortical-basal ganglia activity. Current biology : CB. vol 31. issue 12. 2021-11-15. PMID:33974850. |
together, our findings show that augmented bursting in cbg circuitry drives plasticity in well-learned motor skills, and may inform treatments for basal ganglia movement disorders. |
2021-11-15 |
2023-08-13 |
human |
| Michael Minkley, Patrick MacLeod, Christopher K Anderson, Raad Nashmi, Patrick B Walte. Loss of tyrosine hydroxylase, motor deficits and elevated iron in a mouse model of phospholipase A2G6-associated neurodegeneration (PLAN). Brain research. vol 1748. 2021-10-26. PMID:32818532. |
phospholipase a2g6-associated neurodegeneration (plan) is a rare early-onset monogenic neurodegenerative movement disorder which targets the basal ganglia and other regions in the central and peripheral nervous system; presenting as a series of heterogenous subtypes in patients. |
2021-10-26 |
2023-08-13 |
mouse |
| Lin Shi, Tianshuo Yuan, Shiying Fan, Jie Zheng, Yu Diao, Guofan Qin, Defeng Liu, Guanyu Zhu, Kai Qin, Huanguang Liu, Hua Zhang, Anchao Yang, Fangang Meng, Jianguo Zhan. Comparison of cognitive performance between patients with Parkinson's disease and dystonia using an intraoperative recognition memory test. Scientific reports. vol 11. issue 1. 2021-10-26. PMID:34671073. |
neuroscientific studies on the function of the basal ganglia often examine the behavioral performance of patients with movement disorders, such as parkinson's disease (pd) and dystonia (dt), while simultaneously examining the underlying electrophysiological activity during deep brain stimulation surgery. |
2021-10-26 |
2023-08-13 |
Not clear |
| S Harvey, S Ryan, A Tarrant, M King, B Haye. Basal ganglia echogenicity in preterm infants: A case series. Journal of neonatal-perinatal medicine. vol 14. issue 2. 2021-10-25. PMID:33074194. |
damage to the basal ganglia and thalamus (bgt) can be caused by multiple perinatal factors and may be associated with movement disorders, cognitive delay and visual difficulties. |
2021-10-25 |
2023-08-13 |
Not clear |
| Thomas Wichmann, Mahlon R Delon. Deep-Brain Stimulation for Basal Ganglia Disorders. Basal ganglia. vol 1. issue 2. 2021-10-20. PMID:21804953. |
the realization that medications used to treat movement disorders and psychiatric conditions of basal ganglia origin have significant shortcomings, as well as advances in the understanding of the functional organization of the brain, has led to a renaissance in functional neurosurgery, and particularly the use of deep brain stimulation (dbs). |
2021-10-20 |
2023-08-12 |
Not clear |
| Thomas Wichmann, Mahlon R Delon. Deep-Brain Stimulation for Basal Ganglia Disorders. Basal ganglia. vol 1. issue 2. 2021-10-20. PMID:21804953. |
movement disorders are now routinely being treated with dbs of 'motor' portions of the basal ganglia output nuclei, specifically the subthalamic nucleus and the internal pallidal segment. |
2021-10-20 |
2023-08-12 |
Not clear |
| Adam P Horin, Peter S Myers, Kristen A Pickett, Gammon M Earhart, Meghan C Campbel. Resting-state functional connectivity associated with gait characteristics in people with Parkinson's disease. Behavioural brain research. vol 411. 2021-10-18. PMID:34087255. |
parkinson's disease (pd) is a movement disorder caused by dysfunction in the basal ganglia (bg). |
2021-10-18 |
2023-08-13 |
Not clear |
| Merve Kasap, Donard S Dwye. Na Journal of neural transmission (Vienna, Austria : 1996). vol 128. issue 6. 2021-10-15. PMID:33961117. |
na parkinson's disease (pd) is a debilitating movement disorder often accompanied by neuropsychiatric symptoms that stem from the loss of dopaminergic function in the basal ganglia and altered neurotransmission more generally. |
2021-10-15 |
2023-08-13 |
Not clear |
| Jennifer L Magnusson, Daniel K Leventha. Revisiting the "Paradox of Stereotaxic Surgery": Insights Into Basal Ganglia-Thalamic Interactions. Frontiers in systems neuroscience. vol 15. 2021-09-14. PMID:34512279. |
basal ganglia dysfunction is implicated in movement disorders including parkinson disease, dystonia, and choreiform disorders. |
2021-09-14 |
2023-08-13 |
Not clear |
| Owen M Peters, Alexandra Weiss, Jake Metterville, Lina Song, Robert Logan, Gaynor A Smith, Michael A Schwarzschild, Christian Mueller, Robert H Brown, Marc Freema. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease. Neurobiology of disease. vol 155. 2021-09-03. PMID:33892050. |
parkinson's disease (pd) is the most common form of neurodegenerative movement disorder, associated with profound loss of dopaminergic neurons from the basal ganglia. |
2021-09-03 |
2023-08-13 |
mouse |
| Jakob Wasserthal, Klaus H Maier-Hein, Peter F Neher, Robert C Wolf, Georg Northoff, John L Waddington, Katharina M Kubera, Stefan Fritze, Anais Harneit, Lena S Geiger, Heike Tost, Dusan Hirja. White matter microstructure alterations in cortico-striatal networks are associated with parkinsonism in schizophrenia spectrum disorders. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 50. 2021-08-30. PMID:33984810. |
this study further supports the notion of altered "bottom-up modulation" between basal ganglia and fronto-parietal regions in the pathobiology of parkinsonism, which may reflect an interaction between movement disorder intrinsic to ssd and antipsychotic drug-induced sensorimotor dysfunction. |
2021-08-30 |
2023-08-13 |
Not clear |
| Sarah Hescham, Yasin Teme. Electrical stimulation of the fornix for the treatment of brain diseases. Handbook of clinical neurology. vol 180. 2021-07-28. PMID:34225947. |
deep brain stimulation (dbs) has proven to be safe and effective for both hypo- and hyperkinetic movement disorders of basal ganglia origin, while its application to other neural pathways such as the circuit of papez is under investigation. |
2021-07-28 |
2023-08-13 |
Not clear |